EAGLE HARBOR ASSET MANAGEMENT INC /ADV’s Corcept Therapeutics CORT Stock Holding History

EAGLE HARBOR ASSET MANAGEMENT INC /ADV’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$348K	Buy	+4,000	New	+$242K	0.27%	101

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EAGLE HARBOR ASSET MANAGEMENT INC /ADV's CORT Position: Q2 2026 in Review

EAGLE HARBOR ASSET MANAGEMENT INC /ADV opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 4,000 shares worth $348K. The stake represents 0.27% of the portfolio and ranks #101 among its holdings.

308 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

EAGLE HARBOR ASSET MANAGEMENT INC /ADV held 4,000 shares of Corcept Therapeutics worth $348K as of Q2 2026.
Corcept Therapeutics was a new EAGLE HARBOR ASSET MANAGEMENT INC /ADV position in Q2 2026.
Corcept Therapeutics made up 0.27% of EAGLE HARBOR ASSET MANAGEMENT INC /ADV's portfolio in Q2 2026, its #101 holding.
308 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on EAGLE HARBOR ASSET MANAGEMENT INC /ADV's 13F filing for Q2 2026, filed 11 Aug 2026.